Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jan, 25 2026
Apr, 25 2025
May, 12 2026
Jan, 1 2026
Oct, 12 2025